Moderna
MRNA
#1611
Rank
S$13.17 B
Marketcap
$34.09
Share price
-1.55%
Change (1 day)
-75.01%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$13.17 Billion

As of April 2025 Moderna has a market cap of S$13.17 Billion. This makes Moderna the world's 1611th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025S$13.17 B-37.22%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Apr 3rd, 2025 the market cap of Moderna was reported to be:

S$13.35 Billion
by Nasdaq info icon info icon
S$13.38 Billion
by CompaniesMarketCap info icon info icon
S$13.38 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$0.14 B-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$280.00 B 2,024.77%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$41.66 B 216.13%๐Ÿ‡บ๐Ÿ‡ธ USA
S$282.97 B 2,047.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$1.97 B-84.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$499.39 B 3,689.55%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.00 B-69.59%๐Ÿ‡บ๐Ÿ‡ธ USA